BCAB·09077B104·US·equity·Healthcare - Biotechnology-13D/G
BCAB (BIOATLA INC) is held by 22 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($443,825), GEODE CAPITAL MANAGEMENT, LLC ($110,976), DEUTSCHE BANK AG\ ($84,056). Net institutional sentiment: Mixed.
See how BCAB's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer